{
    "clinical_study": {
        "@rank": "92284", 
        "acronym": "PET/MRI", 
        "arm_group": {
            "arm_group_label": "PET/MR", 
            "arm_group_type": "Other", 
            "description": "Patients must have had radioembolization, within 72 hours of the PET/MR"
        }, 
        "brief_summary": {
            "textblock": "To evaluate y90-PET/MRI (Positron Emission Tomography / Magnetic Resonance Imaging) for its\n      potential on reporting 1) technical success of radioembolization and 2) presence of\n      extrahepatic deposition of microspheres"
        }, 
        "brief_title": "Microsphere Localization Using PET/MRI in Patients With Liver Disease", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Liver Neoplasms", 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Liver Diseases", 
                "Liver Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participant must successfully complete the MRI screening form\n\n          -  Participant must be scheduled to undergo radioembolization for liver disease\n\n          -  Participant must be \u2265 18 years of age\n\n          -  Participant must be able to understand and willing to sign an Institutional Review\n             Board (IRB)-approved written informed consent document\n\n        Exclusion Criteria:\n\n          -  Participant must not have any contraindications to MRI scanning\n\n          -  Patient must not be pregnant or breastfeeding\n\n          -  If agreeing to MRI contrast, participant must not have renal insufficiency\n             (glomerular filtration rate (GFR < 30 mL/min/1.73 m2) measured within the past 60\n             days\n\n          -  If agreeing to MRI contrast, participant must not be on dialysis\n\n          -  If agreeing to MRI contrast, participant must not have had a prior allergic reaction\n             to gadolinium-based contrast agents\n\n          -  PET/MRI is not able to be scheduled within 72 hours of radioembolization"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01744054", 
            "org_study_id": "201209062"
        }, 
        "intervention": {
            "arm_group_label": "PET/MR", 
            "intervention_name": "PET/MR", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 2, 2014", 
        "link": {
            "description": "Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine", 
            "url": "http://www.siteman.wustl.edu"
        }, 
        "location": {
            "contact": {
                "email": "pparikh@radonc.wustl.edu", 
                "last_name": "Parag Parikh, M.D.", 
                "phone": "314-747-9614"
            }, 
            "facility": {
                "address": {
                    "city": "St. Louis", 
                    "country": "United States", 
                    "state": "Missouri", 
                    "zip": "63122"
                }, 
                "name": "Washington University School of Medicine"
            }, 
            "investigator": [
                {
                    "last_name": "Ananya Benegal", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Akash Sharma, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jeff Olsen, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Kathryn Fowler, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Richard LaForest, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jose Garcia-Ramirez, M.S", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Seth Klein, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Nael Saad, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Darryl Zuckerman, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Todd DeWees, Ph.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Pilot Study of Microsphere Localization Using PET/MRI in Patients With Liver Disease Following Radioembolization", 
        "overall_contact": {
            "email": "pparikh@radonc.wustl.edu", 
            "last_name": "Parag Parikh, M.D.", 
            "phone": "314-747-9614"
        }, 
        "overall_official": {
            "affiliation": "Washington University School of Medicine", 
            "last_name": "Parag Parikh, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "An MR diagnostic radiologist and a nuclear medicine physician will evaluate the images and will determine any presence of extrahepatic deposition of microspheres.", 
                "measure": "Evaluate y90-PET/MRI for its potential on reporting presence of extrahepatic deposition of microspheres", 
                "safety_issue": "No", 
                "time_frame": "1 day (one time event for patient)"
            }, 
            {
                "description": "An MR diagnostic radiologist and a nuclear medicine physician will evaluate the images and will determine whether technical success of the procedure can be determined. They will rate the images if they are 'adequate' to report on these two measures.", 
                "measure": "Evaluate y90-PET/MRI for its potential on reporting technical success of radioembolization", 
                "safety_issue": "No", 
                "time_frame": "1 day (one time event for patient)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01744054"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Washington University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Washington University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}